Atria Wealth Solutions Inc. lessened its stake in Xylem Inc. (NYSE:XYL - Free Report) by 35.8% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,763 shares of the industrial products company's stock after selling 2,655 shares during the period. Atria Wealth Solutions Inc.'s holdings in Xylem were worth $616,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Valley National Advisers Inc. grew its stake in shares of Xylem by 84.9% during the first quarter. Valley National Advisers Inc. now owns 220 shares of the industrial products company's stock worth $26,000 after acquiring an additional 101 shares during the last quarter. Maseco LLP purchased a new stake in shares of Xylem during the second quarter worth about $31,000. ST Germain D J Co. Inc. grew its stake in shares of Xylem by 950.0% during the second quarter. ST Germain D J Co. Inc. now owns 252 shares of the industrial products company's stock worth $33,000 after acquiring an additional 228 shares during the last quarter. Center for Financial Planning Inc. grew its stake in shares of Xylem by 52.0% during the first quarter. Center for Financial Planning Inc. now owns 266 shares of the industrial products company's stock worth $32,000 after acquiring an additional 91 shares during the last quarter. Finally, Signature Resources Capital Management LLC purchased a new stake in shares of Xylem during the second quarter worth about $39,000. Hedge funds and other institutional investors own 87.96% of the company's stock.
Insider Transactions at Xylem
In other Xylem news, CAO Geri-Michelle Mcshane sold 1,000 shares of the business's stock in a transaction that occurred on Friday, September 5th. The stock was sold at an average price of $139.96, for a total value of $139,960.00. Following the completion of the transaction, the chief accounting officer directly owned 2,957 shares of the company's stock, valued at approximately $413,861.72. The trade was a 25.27% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 0.27% of the company's stock.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently weighed in on XYL shares. Mizuho boosted their price target on Xylem from $125.00 to $140.00 and gave the stock a "neutral" rating in a research note on Friday, September 12th. Cowen restated a "hold" rating on shares of Xylem in a research note on Tuesday, August 26th. Citigroup boosted their price target on Xylem from $168.00 to $173.00 and gave the stock a "buy" rating in a research note on Thursday, October 9th. TD Cowen lifted their target price on Xylem from $125.00 to $130.00 and gave the stock a "hold" rating in a report on Tuesday, August 26th. Finally, Wall Street Zen raised Xylem from a "hold" rating to a "buy" rating in a report on Saturday, August 9th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $154.67.
View Our Latest Report on XYL
Xylem Trading Up 0.8%
Xylem stock opened at $146.00 on Friday. The company has a quick ratio of 1.43, a current ratio of 1.90 and a debt-to-equity ratio of 0.17. Xylem Inc. has a 52 week low of $100.47 and a 52 week high of $151.16. The company has a market capitalization of $35.54 billion, a price-to-earnings ratio of 37.92, a price-to-earnings-growth ratio of 2.49 and a beta of 1.13. The stock has a 50-day moving average price of $143.32 and a 200 day moving average price of $131.29.
Xylem (NYSE:XYL - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The industrial products company reported $1.26 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.15 by $0.11. Xylem had a return on equity of 10.33% and a net margin of 10.74%.The company had revenue of $2.30 billion during the quarter, compared to the consensus estimate of $2.20 billion. During the same period in the previous year, the company posted $1.09 earnings per share. Xylem's revenue for the quarter was up 6.1% on a year-over-year basis. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. Sell-side analysts anticipate that Xylem Inc. will post 4.65 EPS for the current year.
Xylem Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Thursday, August 28th were issued a $0.40 dividend. The ex-dividend date of this dividend was Thursday, August 28th. This represents a $1.60 dividend on an annualized basis and a yield of 1.1%. Xylem's payout ratio is presently 41.56%.
Xylem Profile
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Read More
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.